封面
市場調查報告書
商品編碼
1451711

2024-2032 年按類型、技術(微陣列、即時定量聚合酶鍊式反應、定序技術)、應用、最終用戶和地區分類的轉錄組學市場報告

Transcriptomics Market Report by Type, Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies), Application, End User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2023年,全球轉錄組學市場規模達到72億美元。展望未來, IMARC Group預計到2032年市場規模將達到118億美元,2024-2032年複合年成長率(CAGR)為5.44%。

轉錄組學是對任何生物的基因型在特定時間、條件或細胞產生的核糖核酸 (RNA) 轉錄本的分析。它將基因組、蛋白質組和細胞表現型連結起來。轉錄組學涵蓋與 RNA 相關的一切,包括它們的轉錄和表達水平、功能、位置、運輸和分解。轉錄組學利用微陣列分析、即時定量聚合酶鍊式反應 (Q-PCR) 和定序技術來確定基因的轉錄結構。它還幫助研究人員表徵轉錄活性,重點關注相關目標基因和轉錄本的子集,並識別響應和抵消生物和非生物環境脅迫的基因和途徑。

轉錄組學市場趨勢:

全球對個人化醫療的需求不斷成長,為市場創造了積極的前景。由於 PCR 應用數量的增加以及該領域的進步(例如 RNA 定序的廣泛使用),轉錄組學得到了廣泛的應用。與此一致的是,在研究應用中獲取遺傳資訊對RNA定序的需求不斷成長也有利於市場的成長。 RNA 定序徹底改變了轉錄組分析,能夠在單一研究中量化基因表現水平,以及新基因、剪接亞型、融合轉錄本的親和力,以及對非編碼 RNA 領域的非凡研究。除此之外,主要參與者不斷致力於開發疾病和診斷的新穎儀器和技術,這反過來又促進了市場成長。此外,推出具有全轉錄組定序 (WTS) 功能的先進基因分析產品,可提供詳細的 RNA 定序分析,對市場成長產生了積極影響。除此之外,廣泛的研究和開發(R&D)活動、由於Covid-19疾病的爆發而對轉錄組學的需求不斷增加,以及各種政府舉措和組學資金的實施正在支持市場的成長。

本報告回答的關鍵問題

  • 2023年全球轉錄組學市場規模有多大?
  • 2024-2032年全球轉錄組學市場的預期成長率是多少?
  • 推動全球轉錄組學市場的關鍵因素是什麼?
  • COVID-19 對全球轉錄組學市場有何影響?
  • 全球轉錄組學市場按類型分類是怎樣的?
  • 基於該技術的全球轉錄組學市場的詳細情形如何?
  • 基於應用的全球轉錄組學市場的細分如何?
  • 全球轉錄組學市場的關鍵區域有哪些?
  • 全球轉錄組學市場的主要參與者/公司有哪些?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球轉錄組市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:市場區隔:按類型

  • 儀器
    • 市場走向
    • 市場預測
  • 耗材
    • 市場走向
    • 市場預測
  • 軟體
    • 市場走向
    • 市場預測
  • 服務
    • 市場走向
    • 市場預測

第 7 章:市場區隔:依技術

  • 微陣列
    • 市場走向
    • 市場預測
  • 即時定量聚合酶鍊式反應 (Q-PCR)
    • 市場走向
    • 市場預測
  • 定序技術
    • 市場走向
    • 市場預測

第 8 章:市場區隔:按應用

  • 診斷和疾病分析
    • 市場走向
    • 市場預測
  • 藥物發現
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章:市場區隔:按最終用戶

  • 學術及研究機構
    • 市場走向
    • 市場預測
  • 製藥公司
    • 市場走向
    • 市場預測
  • 生技公司
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章:市場區隔:按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分:按國家/地區
    • 市場預測

第 11 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章:價值鏈分析

第 13 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章:價格分析

第15章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • Biospyder Technologies Inc.
    • Illumina Inc.
    • Nanostring Technologies Inc.
    • Qiagen
    • Roche Holding AG
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A6585

The global transcriptomics market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.44% during 2024-2032.

Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.

Transcriptomics Market Trends:

The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, application and end user.

Breakup by Type:

Instruments

Consumables

Software

Services

Breakup by Technology:

Microarray

Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)

Sequencing Technologies

Breakup by Application:

Diagnostics and Disease Profiling

Drug Discovery

Others

Breakup by End User:

Academic and Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global transcriptomics market in 2023?
  • 2. What is the expected growth rate of the global transcriptomics market during 2024-2032?
  • 3. What are the key factors driving the global transcriptomics market?
  • 4. What has been the impact of COVID-19 on the global transcriptomics market?
  • 5. What is the breakup of the global transcriptomics market based on type?
  • 6. What is the breakup of the global transcriptomics market based on the technology?
  • 7. What is the breakup of the global transcriptomics market based on the application?
  • 8. What are the key regions in the global transcriptomics market?
  • 9. Who are the key players/companies in the global transcriptomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcriptomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing Technologies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Diagnostics and Disease Profiling
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Academic and Research Institutes
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharmaceutical Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 BGI Group
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Bio-Rad Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biospyder Technologies Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Illumina Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Nanostring Technologies Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Qiagen
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Roche Holding AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Takara Bio Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Transcriptomics Market: Major Drivers and Challenges
  • Figure 2: Global: Transcriptomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transcriptomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transcriptomics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Transcriptomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Transcriptomics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Transcriptomics Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Transcriptomics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Transcriptomics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Transcriptomics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Transcriptomics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Transcriptomics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Transcriptomics (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Transcriptomics (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Transcriptomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Transcriptomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Transcriptomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Transcriptomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Transcriptomics (Sequencing Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Transcriptomics (Sequencing Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Transcriptomics (Diagnostics and Disease Profiling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Transcriptomics (Diagnostics and Disease Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Transcriptomics (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Transcriptomics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Transcriptomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Transcriptomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Transcriptomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Transcriptomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Transcriptomics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Transcriptomics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Transcriptomics (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Transcriptomics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Transcriptomics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Transcriptomics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Transcriptomics Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Transcriptomics Industry: SWOT Analysis
  • Figure 87: Global: Transcriptomics Industry: Value Chain Analysis
  • Figure 88: Global: Transcriptomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcriptomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transcriptomics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Transcriptomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Transcriptomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Transcriptomics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Transcriptomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Transcriptomics Market: Competitive Structure
  • Table 8: Global: Transcriptomics Market: Key Players